Skip to main content
Journal cover image

MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH

Publication ,  Conference
Macias, E; Corcoran, D; Chi, J-T; Freedland, S
Published in: Journal of Urology
April 2017

Duke Scholars

Published In

Journal of Urology

DOI

EISSN

1527-3792

ISSN

0022-5347

Publication Date

April 2017

Volume

197

Issue

4S

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Macias, E., Corcoran, D., Chi, J.-T., & Freedland, S. (2017). MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH. In Journal of Urology (Vol. 197). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.juro.2017.02.3089
Macias, Everardo, David Corcoran, Jen-Tsan Chi, and Stephen Freedland. “MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH.” In Journal of Urology, Vol. 197. Ovid Technologies (Wolters Kluwer Health), 2017. https://doi.org/10.1016/j.juro.2017.02.3089.
Macias E, Corcoran D, Chi J-T, Freedland S. MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2017.
Macias, Everardo, et al. “MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH.” Journal of Urology, vol. 197, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2017. Crossref, doi:10.1016/j.juro.2017.02.3089.
Macias E, Corcoran D, Chi J-T, Freedland S. MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2017.
Journal cover image

Published In

Journal of Urology

DOI

EISSN

1527-3792

ISSN

0022-5347

Publication Date

April 2017

Volume

197

Issue

4S

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Urology & Nephrology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences